Swiss pharmaceuticals manufacturer Novartis AG received mixed news from European and American regulators on 18 April, with the European Medicines Agency (EMA) approving its multiple sclerosis drug ...
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec is certainly hoping so. The biotech's multiple sclerosis drug Tecfidera received a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results